Ceritinib dihydrochloride CAS:1380575-43-8
Ceritinib dihydrochloride
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-2187 | 200mg | 255.00 | + Add to cart |
|
| R-C-2187 | 500mg | 500.00 | + Add to cart |
|
| R-C-2187 | 1g | 855.00 | + Add to cart |
|
|
|
||||
Product description
Ceritinib dihydrochloride(LDK378 dihydrochloride)is a selective, orally bioavailable and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM.Ceritinib dihydrochloride(LDK378 dihydrochloride)also inhibits IGF-1R,InsR,and STK22D with IC50 values of 8,7,and 23nM,respectively.Ceritinib dihydrochloride(LDK378 dihydrochloride)shows great antitumor potency.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 2 years |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---Ceritinib dihydrochloride
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


